| http://www.w3.org/ns/prov#value | - More than a dozen phase III trials More than 60 phase II trials Most large patient population disease states are covered by the trials including various cancers, heart disease, vision loss, movement loss, stroke, and MS Specific to cancer, BioLife has more than a dozen customers working to commercialize cell-based immunotherapies Annual product revenue per clinical trial stage product, if approved
|
